BI is an international pharmaceutical company which is doing business in the development and marketing of new pharmaceutical products, in particular in the therapeutical area of Respiratory. As an innovative, research-driven company it feels responsible for the support of research & development and education of healthcare professionals.
https://www.boehringer-ingelheim.com/ AMOUNT: 90.000 Euros
Boehringer Ingelheim supports the Pneumo Update Europe 2020 as Premium Partner.
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
www.novartis.com/ AMOUNT: 90.000 Euros
Novartis supports the Pneumo Update Europe 2020 as Platinum Partner.
The platform aims to bring more awareness to severe asthma, elevate the latest science around type 2 inflammation, and empower people to take action to strive towards better asthma control.
www.thenextbreath.com AMOUNT: 50.000 Euros
Sanofi Genzyme supports the Pneumo Update Europe 2020 as Gold Partner.
CSL Behring's portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.
https://www.cslbehring.com/ AMOUNT: 35.000 Euros
CSL Behring supports the Pneumo Update Europe 2020 as Silver Partner.
